RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - RECETTORI PURINERGICI E NEUROPROTEZIONE
• 2 - Identificazione, espressione funzionale e caratterizzazione fisiopatologica di nuovi recettori purinici.
• 3 - Transcrittomica e proteomica dello scompenso cardiaco umano per l'individuazione di nuovi meccanismi patogenetici e biomarcatori: focus sui recettori purinergici P2
• 4 - I recettori metabotropici del glutammato com "targets" di farmaci neuroprotettivi
• 5 - Studio dei mosaici recettoriali a livello dei gangli della base: implicazioni fisiopatologiche e terapeutiche
• 6 - Agenti Attivi sul Sistema Nervoso Centrale: Moderni Approcci Chimico-Farmaceutici per la Modulazione e Caratterizzazione di Pathways Recettoriali
• 7 - Il sistema nocicettina/OFQ-recettore NOP: studi di base e clinici
• 8 - Progettazione, sintesi e valutazioni bio-farmacologiche preliminari di ligandi utili allo sviluppo di farmaci per le patologie neurodegenerative del S.N.C. - Un approccio multirecettoriale.
• 9 - Potenziale terapeutico di nuovi ligandi per il recettore di nocicettina/orfanina FQ
• 10 - CONTROLLO DEL CICLO CELLULARE DA LIGANDI DI RECETTORI NUCLEARI

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze chimiche
  • CHIMICA FARMACEUTICA
• Area scientifico disciplinare: Scienze biologiche
  • BIOCHIMICA
  • BIOLOGIA APPLICATA
  • FARMACOLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

Classificazione geografica

• Regione: Lombardia

Bibliografia

Abbracchio MP, Burnstock G. 1994. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475.

Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G. 2003. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24: 52-55.

Amadio S, D’Ambrosi N, Cavaliere F, Murra B, Sancesario G, Bernardi G, Burnstock G, Volonté C. 2002. P2 receptor modulation and cytotoxic function in cultured CNS neurones. Neuropharmacol 42: 489-501.

Armstrong JN, Brust TB, Lewis RG, Mac Vicar BA. 2002. Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. J Neurosci 22: 5938-5945.

Blom MAA, van Twillert MGH, de Vries SC, Engels F, Finch CE, Veerhuis R, Eikelenboom P. 1997. NSAIDs inhibit the IL-b1-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. Brain Res 777: 210-218.

Boué-Grabot E, Barajas-Lopez C, Chakfe Y, Blais D, Belanger D, Emerit MB, Seguela P. 2003. Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels. J Neurosci 23: 1246-1253.

Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP. 1999. Cyclo-oxygenase 2 mediates P2Y-receptor-induced reactive astrogliosis. Br J Pharmacol 126: 563-567.

Brambilla R, Neary JT, Cattabeni F, Cottini L, D’Ippolito GL, Schiller P, Abbracchio MP. 2002. Induction of COX-2 and reactive astrogliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signaling. J Neurochem 83: 1285-1296.

Catteral WA. 1999. Interactions of presynaptic Ca++channels and snare proteins in neurotransmitter release. Ann N Y Acad Sci 868: 144-159.

Cavaliere F, Sancesario G, Bernardi G, Volonte’ C. 2002. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors. J Neurochem 83: 1-10.

Cavaliere, F., Florenzano, F., Amadio, S., Fusco, F.R, Viscomi, M.T., D’Ambrosi N., Vacca F., Sancesario G., Bernardi G., Molinari M., Volonté C. 2003. Up regulation of P2X2 and P2X4 receptors during ischemic cell death: prevention by P2 antagonists". Neurosci. 120 (1):85-98.

Cavaliere, F., Amadio, S., Sancesario, G., Bernardi, and Volonté, C. 2004. Synaptic P2X7 and oxygen/glucose deprivation in hippocampal organotypic cultures . J. Cer. Bl. Fl. Metab . 24(3) 2004 In press

Cormet-Boyaka E, Di A, Chang SY, Naren AP, Tousson A, Nelson DJ, Kirk KL. 2002. CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex. Proc Natl Acad Sci 99: 12477-12482.

Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF, Buckley NJ, Parson SH, Deuchars J. 2001. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21:7143-7152.

Duan S, Anderson CM, Keung EC, Chen Y, Chen Y, Swanson RA. 2003. P2X7 receptor-mediated release of excitory amino acids from astrocytes. J Neurosci 23:1320-1328.

Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. 1994. Nomenclature and classification of purinoceptors. Pharm Rev 46: 143-156.

Fumagalli M, Brambilla R, D’Ambrosi N, Volontè C, Matteoli M, Verderio C, Abbracchio MP. 2003. Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43(3): 218-230, 2003.

Fumagalli M, Trincavelli L, Lecca D, Martini C, Ciana P, Abbracchio MP 2004. Cloning, pharmacological characterization and distribution of the rat G-protein-coupled P2Y13 receptor. Biochem Pharmacol., in press

Gebicke-Haerter PJ, Van Calker D, Norenberg W, Illes P. 1996, Molecular mechanisms of microglial activation. Implications for regeneration and neurodegenerative diseases. Neurochem Int 29:1-12.

Hibell AD, Thompson KM, Simon J, Xing M, Humphrey PP, Michel AD 2001. Complexity of measuring antagonist potency at P2X7 receptor orthologs. J Pharmacol Exp Ther 296:947-957.

Inbe H, Watanabe S, Miyawaki M, Tanabe E, Encinas JA. 2004. Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine. J Biol Chem in press, published on-line on March 4, M400360200

Jacobson KA, Jarvis MF, Willimas M. 2002. Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45:4057-4093.

Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP. 2001. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharm Rev 53:107-118.

Kim M, Jiang LH, Wilson HL, North RA, Surprenant A. 2001. Proteomic and functional evidence for a P2X7 receptor signalling complex. The EMBO J 22:6347-6358.

Lasley RD, Narayan P, Uittenbogaard A, Smart EJ. 2000. Activated cardiac adenosine A(1) receptors translocate out of caveolae. J Biol Chem 275:4417-4421.

Melani A, Pantoni L, Corsi C, Bianchi L, Monopoli A, Bertorelli R, Pepeu G, Pedata F. 1999. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion. Correlations with neurological deficit and histopathological damage. Stroke 30:2448-2455.

Nandanan E, Camaioni E, Jang SY, Kim YC, Cristalli G, Herdewijn P, Secrist 3rd JA, Tiwari KN, Mohanram A, Harden TK, Boyer JL, Jacobson KA. 1999. Structure-activity relationships of biphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J Med Chem 42.1625-1638

Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G. 1996. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19:13-18.

North RA, Surprenant A. 2000. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580.

Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. 2000. Crystal structure of rhodopsin: a G-protein-coupled receptor. Science 289:739-745.

Popoli P, Blum D Pintor A, Tebano MT, Frank C, Gianfriddo M, Domenici MR, Schiffmann SN, Pedata F 2004. The controversial role of adenosine A2A receptor antagonists as neuroprotective agents. Current Medicinal Chemistry-Central Nervous System Drugs. 4, 35-45.

Razani B, Woodman S, Lisanti MP. 2002. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54:431-467.

Ribeiro JA, Sebastiao AM, de Mendonca A. 2003. Participation of adenosine receptors in neuroprotection. Drug News Perspect 16(2):80-6.

Saxena S, Quick MW, Warnock DG. 2000. Interaction of syntaxins with epithelial ion channels. Curr Opin Nephrol Hypertens 9:523-527.

Sperlagh B, Kofalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, Vizi ES. 2002. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J Neurochem 81:1196-1211.

Trincavelli ML, Tuscano D, Marroni M, Klotz KN, Lucacchini A, Martini C. 2002. Involvement of mitogen protein kinase cascade in agonist-mediated human A3 adenosine receptor regulation. Biochem Biophys Acta 1591:55-62.

Volonté, C., Merlo, D. 1996. Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons" J. Neurosci. Res. 45: 183-193.

Volonté, C., Amadio, S., Cavaliere, F., D’Ambrosi, N., Vacca F., Bernardi G. 2003. Extracellular ATP and neurodegeneration in the nervous system. Current DrugTargets: CNSND 2 (6): 402-413.

Yoshioka K, Saitoh O, Nakata H. 2002. Agonist-promoted heteromeric oligomerization between adenosine A1 and P2Y1 receptors in living cells. FEBS Lett 523:147-151.

Parole Chiave

RECETTORI PURINERGICI P2; SINTESI DI NUOVI AGONISTI E ANTAGONISTI SELETTIVI PER I VARI SOTTOTIPI DI RECETTORI P2; MODELLI CELLULARI DI ASTROGLIOSI REATTIVA; MODELLI CELLULARI DI NEURODEGENERAZIONE; ISCHEMIA FOCALE PERMANENTE NEL RATTO; LOCALIZZAZIONE SUBCELLULARE E IN MICRODOMINI DI MEMBRANA DEI RECETTORI P2; SINTESI E TRAFFICO INTRACELLULARE DEI RECETTORI P2; FORMAZIONE DI OMO- E ETERO-OLIGOMERI RECETTORIALI; PROTEOMICA DEI RECETTORI P2